Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 1279-1286, April 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pera, M. F.
Right arrow Articles by Harder, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pera, M. F., Jr.
Right arrow Articles by Harder, H. C.

Effects of Mannitol or Furosemide Diuresis on Cis-Dichlorodiammineplatinum(II) Antitumor Activity and Toxicity to Host-renewing Cell Populations in Rats1

Martin F. Pera, Jr.2 and Harold C. Harder3

Department of Pharmacology, The George Washington University Medical Center, Washington, D.C. 20037 [M. F. P., H. C. H.], and Department of Pharmacology, Oral Roberts University, Tulsa, Oklahoma 74171 [H. C. H.]

Administration of mannitol (300 mg in 3.0 ml 0.45% NaCl solution as a 30-min i.v. infusion) but not furosemide (12.5 mg/kg i.p. with 6.0 ml 0.9% NaCl solution significantly reduced acute (14-day) lethality in normal male F344 rats given cis-dichlorodiammineplatinum(II) (CDDP) (8.5 mg/kg i.v.). Because both diuretics protected rats (from CDDP impairment of renal function and because a 30-min i.v. infusion of 3.0 ml 0.45% NaCl solution with CDDP (8.5 mg/kg) resulted in lower blood urea nitrogen levels but did not reduce mortality in F344 rats, it was concluded that prevention of acute lethality with mannitol was not directly related to protection of renal function. Other tissues, particularly gastrointestinal mucosa and bone marrow, were therefore studied. F344 rats given CDDP (6.0 mg/kg i.v., a sublethal dose) and rats given CDDP (8.5 mg/kg i.v.) with mannitol exhibited faster recovery of [methyl-3H]thymidine incorporation into intestinal DNA when compared to rats given CDDP (8.5 mg/kg i.v.) alone or with furosemide. Femoral nucleated cell numbers and spleen, thymus, and body weights recovered more rapidly in F344 rats given CDDP (6.0 mg/kg i.v.) with mannitol compared to animals given the same dose of CDDP alone or with furosemide.

The percentage of increase in life span of male Sprague-Dawley rats inoculated with 2.5 x 106 Shay leukemia cells i.v. and treated 3 days later with CDDP (7.0 mg/kg i.v.) was unchanged by the administration of mannitol or furosemide with CDDP. When manitol was administered with CDDP (9.5 mg/kg i.v.), a dose of the platinum drug that causes substantial mortality in Sprague-Dawley rats when given alone, tumor-bearing animals given the high dose with mannitol survived longer than those given CDDP (7.0 or 9.5 mg/kg i.v.) alone. In the systems described, it appears that mannitol selectively spared rapidly proliferating host tissues as well as the kidney from CDDP toxicity and thereby improved the therapeutic index of this drug.

1 Supported by Grant Cl-107 from the American Cancer Society and by Grant CA-02978 from the National Cancer Institute, Department of Health, Education, and Welfare. A portion of this work has been reported previously in abstract form (9).

2 From a dissertation to be presented to the Graduate School of Arts and Sciences, The George Washington University in partial fulfillment of the requirements for the Ph.D. degree.

3 To whom all correspondence should be addressed, at Oral Roberts University.

Received 7/24/78. Accepted 1/ 3/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.